Zymewire, a SaaS company with over 300 clients across the drug development sector, has announced the launch of CovidCollaborators.org, an online directory of expert, pro-bono, and discounted clinical development services being offered in the fight against COVID-19.
COVID Collaborators aims to connect service providers with researchers working on novel treatments and vaccines for COVID-19. Some of the services being offered include clinical research, clinical software, EDC, manufacturing, investigator training, patient recruitment, use of facilities, virtual services, and clinical trial management.
“The Zymewire team was looking for ways to help accelerate the timeline toward a treatment or vaccine,” said Pete Bastedo, CEO at Zymewire. “We realized that with direct relationships with the world’s leading drug development service companies, we were in a unique position to build something like this. By listing the services and expertise being offered by these companies in a centralized directory, our hope is that it gains the attention of drug developers around the globe, and that together, they can quickly bring new drugs to market.”
If your organization has expertise to contribute to the fight against COVID-19, or if you’re a researcher seeking assistance, Zymewire invites you to become a COVID Collaborator. There is no cost associated with listing or accessing offerings.
Including Women of Childbearing Age in Clinical Research
March 26th 2024In recognition of International Women's Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and Marie Teil, Global Head of UCB’s Women of Childbearing Age Program. They speak about the specific challenges women with chronic illnesses face when accessing appropriate treatment and participating in clinical trials, UCB's Women of Childbearing Age Program and it’s most successful strategies, and much more.
Using Patient Reported Outcomes in Dermatology Trials
April 25th 2024In part 3 of this video interview with ACT editor Andy Studna, Melissa Mooney, director, eCOA sales engineering, IQVIA sheds light on the unique challenges of dermatology trials and how clinical outcome assessments can be implemented in them.
Improving Engagement While Maintaining Data Integrity & Validity
March 19th 2024In recognition of Women's Health Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and uMotif's Chief Product Officer, Julia Lakeland, discuss new technologies improving patient engagement and reducing the emotional and logistical burdens of participation, ethical considerations that should be addressed when implementing those technologies, while ensuring patient privacy, and much more.